Condition
Dense Breasts
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04067726Phase 2Active Not RecruitingPrimary
RANKL Inhibition and Mammographic Breast Density
NCT07114679Not ApplicableNot Yet Recruiting
Molecular Breast Imaging (MBI)-Guided Biopsy
NCT01240278CompletedPrimary
Histology of Functional Density in Postmenopausal Breast
NCT01588834CompletedPrimary
Histology of Functional Density in Premenopausal Breast
Showing all 4 trials